Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dextromethorphan inhibits NMDA-induced convulsions.

J W Ferkany1, S A Borosky, D B Clissold

  • 1Nova Pharmaceutical Corporation, Baltimore, MD 21224-2788.

European Journal of Pharmacology
|June 22, 1988
PubMed
Summary

Dextromethorphan effectively blocked N-methyl-D-aspartate (NMDA)-induced seizures in mice. This suggests dextromethorphan may exert its effects through interaction with excitatory amino acid receptors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.

Molecular psychiatry·2014
Same author

Cognition and amyloid load in Alzheimer disease imaged with florbetapir F 18(AV-45) positron emission tomography.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2013
Same author

The use of the exploratory IND in the evaluation and development of 18F-PET radiopharmaceuticals for amyloid imaging in the brain: a review of one company's experience.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2009
Same author

Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin.

Neuroscience letters·2000
Same author

Long-term treatment of girls with ornithine transcarbamylase deficiency.

The New England journal of medicine·1996
Same author

Further developments in the measurement of working memory in rodents.

Brain research. Cognitive brain research·1996

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurochemistry

Background:

  • N-methyl-D-aspartate (NMDA) receptors are crucial for excitatory neurotransmission.
  • Dysregulation of NMDA receptor activity is implicated in various neurological conditions.
  • Understanding NMDA receptor antagonists is vital for developing novel therapeutics.

Purpose of the Study:

  • To evaluate the anticonvulsant properties of dextromethorphan and its metabolite, dextrorphan.
  • To assess the efficacy of various NMDA receptor antagonists in a specific seizure model.
  • To explore the potential role of excitatory amino acid receptors in dextromethorphan's pharmacological actions.

Main Methods:

  • Male CF-1 mice were utilized for the study.
  • Intraperitoneal administration of test compounds.

Related Experiment Videos

  • Induction of seizures using N-methyl-D-aspartate.
  • Evaluation of anticonvulsant activity against NMDA-induced convulsions.

    • Main Results:

    • Dextromethorphan and dextrorphan demonstrated significant anticonvulsant effects.
    • Competitive and noncompetitive NMDA antagonists also successfully blocked seizures.
    • Standard anticonvulsants like phenytoin were ineffective in this model.

    Conclusions:

    • Dextromethorphan exhibits potent NMDA receptor antagonist activity.
    • The findings support the hypothesis that dextromethorphan's pharmacological effects involve NMDA receptor interactions.
    • This study provides evidence for dextromethorphan's potential as an anticonvulsant agent targeting excitatory amino acid pathways.